Performance and Portfolio Update
- The Pax Global Opportunities Fund outperformed the MSCI ACWI in the second quarter of 2021.
- On a relative basis, positive contribution came from stock selection in Health Care. This offset negative stock selection in Financials, where the Fund has low exposure to interest-sensitive names, and Information Technology, where the Fund is less exposed to the high growth names in the sector. In addition, the lack of exposure to the Energy sector hurt relative performance.
- Health Care names led performance over the quarter on the back of good earnings and positive announcements. Lonza (Life Sciences Tools & Services, Switzerland) benefited from the United States Food and Drug Administration’s (USFDA) approval of Biogen’s treatment for Alzheimer’s, as the news increased investor comfort levels around demand dynamics for biologics and reduced the risk of overcapacity. Evotec (Life Sciences Tools & Services, Germany) has benefited from a combination of a rapid succession of deal announcements, strong full year results and good guidance for 2021. Equinix (Specialized real estate investment trusts (REITs), United States) rebounded after a positive reception to its Capital Markets Day, where the company upgraded its long-term margin guidance, outlined growth opportunities in its digital infrastructure business and provided more details on its hyperscale joint venture.
- During the quarter, underperformance was largely stock specific. Having performed well on the announcement earlier in the year that they would spin off their US business, Prudential (Life & Health Insurance, United Kingdom) lagged after announcing the de-merger would be delayed until the second half of the year due to additional regulatory filings. Kubota (Agriculture & Farm Equipment, Japan) underperformed after strong year-to-date performance due to concerns that the steepening US yield curve may impact the competitiveness and profitability of the company’s equipment financing operations. Ecolab (Specialty Chemical, United States) underperformed as Q1 2021 results continued to be impacted by lingering COVID-19 headwinds in the hospitality and lodging-related business segment.
- The lifting of COVID-19 restrictions and rapid progress of vaccination programs have resulted in an acceleration in economic activity. Gross Domestic Product (GDP) and earnings growth are expected to continue to recover sharply during 2021, driven by pent up demand as economies open further and consumer and business confidence returns. As confidence increases, bond yields, commodities and inflation have risen, triggering a rotation in the equity market away from quality. While the rise in inflation has brought forward the expected timing of the next US interest rate hike, Impax believes the current inflation impulse will be transitory and that as the recovery matures, high quality companies benefiting from the transition to a more sustainable economy will continue to present attractive long-term investment opportunities.
- The investment team remains focused on companies demonstrating consistent growth and operational return profiles coupled with lower debt levels. Areas of interest include beneficiaries of increased spending on drug discovery and testing, the accelerating digital transformation of enterprises, companies providing access to finance and businesses enabling the sharing economy.
Performance(as of 6/30/21)
|1-Month||Quarter||YTD||1 Year||3 Year||5 Year||10 Year||Since Inception1|
|Pax Global Opportunities Fund - Investor Class||0.89||7.50||8.53||36.28||17.84||-||-||17.68|
|Pax Global Opportunities Fund - Institutional Class||0.96||7.56||8.66||36.62||18.06||-||-||17.91|
|MSCI ACWI (Net) Index||1.32||7.39||12.30||39.26||14.57||-||-||14.80|
|Lipper Global Multi-Cap Growth Funds Index||2.84||8.04||10.87||42.88||19.95||-||-||20.27|
Performance data quoted represent past performance, which does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. To obtain performance for the most recent month-end, call 800.767.1729 or visit impaxam.com
Figures include reinvested dividends, capital gains distributions and changes in principal value.
1The inception date for the Pax Global Opportunities Fund Institutional Class and the Investor Class is June 27, 2018.
ˆTotal annual Global Opportunities Fund operating expenses, gross of any fee waivers or reimbursements, for Institutional Class and Investor Class are 1.31% and 1.56%, respectively, as of 5/1/2021 prospectus. Total annual Global Opportunities Fund operating expenses, net of any fee waivers, reimbursements and acquired fund fees and expenses, for Institutional Class and Investor Class, shares were 0.98% and 1.23%, respectively.
(3/31/21 - 6/30/21)
Sector: Average Active Weights (%)
|Total Relative Contribution (%)|
XOther: ETFs (for short-term cash mgmt. purposes) and Cash & Equivalents.
Past performance is no guarantee of future results. Short-term performance may not be indicative of long-term results.
Portfolio Characteristics(as of 6/30/21)
|Market Cap (weighted avg.)∱||$197,423M||$343,212M|
|Number of Securities||41||2,972|
Top 10 Holdings
(as of 6/30/21)
Microsoft Corp. 4.4%, IQVIA Holdings, Inc. 3.7%, Linde PLC 3.5%, HDFC Bank, Ltd. 3.4%, MasterCard, Inc., Class A 3.4%, Prudential PLC 3.3%, Equinix, Inc. 3.3%, Evotec SE 3.1%, Cadence Design Systems, Inc. 3.1% and Taiwan Semiconductor Manufacturing Co., Ltd. 3.0%. Holdings are subject to change.
ƒWeighted Average is an average in which each quantity to be averaged is assigned a weight. These weightings determine the relative importance of each quantity on the average.
∼Forward Price-Earnings Ratio or P/E FY1 ratio is a ratio for valuing a company that measures its current share price relative to its per-share earnings over the next 12 months.
∘Return on Equity: The amount of net income returned as a percentage of shareholders’ equity. Return on equity measures a corporation’s profitability by revealing how much profit a company generates with the money shareholders have invested.
∞An Ex-Ante Beta is used for Funds with less than two years of performance history under its new mandate. The Ex-Ante Beta is calculated using a multi-factor risk model. Beta explains common variations in stock returns due to different stock sensitivities to the market relative to its underlying benchmark for the current period, not historical. A beta for a benchmark is 1.00: A beta greater than 1.00 indicates above average volatility and risk.
The statements and opinions expressed are those of the author as of the date of this report. All information is historical and not indicative of future results and subject to change. This information is not a recommendation to buy or sell any security. Past performance does not guarantee future results.